CalciMedica is trading at $0.73 (5.9%) up today, extending an idiosyncratic rebound after recent sharp declines.
- There are no fresh earnings, FDA updates, M&A news, or notable filings to explain the move, and yesterday’s after-hours strength was also labeled as lacking a clear catalyst.
- The stock appears to be recovering on technical or speculative interest, building momentum despite a lack of fundamental news.
- The upward move comes against a broadly weaker market backdrop.